Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | -- | 6.03M | 16.28M | 3.01M | 3.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 6.03M | 16.28M | 3.01M | 3.49M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 6.03M | 16.28M | 3.01M | 3.49M |
| SG&A Expenses | 663.00K | 878.00K | 1.11M | 1.24M | 1.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 663.00K | 878.00K | 995.00K | 2.70M | 11.59M |
| Operating Income | -663.00K | 5.15M | 15.29M | 318.00K | -8.10M |
| Income Before Tax | -505.00K | 5.50M | 14.15M | -431.00K | -7.84M |
| Income Tax Expenses | -43.00K | 96.00K | -- | -- | -- |
| Earnings from Continuing Operations | -462.00K | 5.41M | 14.15M | -431.00K | -7.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -462.00K | 5.41M | 14.15M | -431.00K | -7.84M |
| EBIT | -663.00K | 5.15M | 15.29M | 318.00K | -8.10M |
| EBITDA | -659.00K | 5.16M | 15.31M | 341.00K | -8.06M |
| EPS Basic | -0.02 | 0.20 | 0.53 | -0.02 | -0.29 |
| Normalized Basic EPS | -0.01 | 0.13 | 0.36 | 0.01 | -0.18 |
| EPS Diluted | -0.02 | 0.20 | 0.53 | -0.02 | -0.29 |
| Normalized Diluted EPS | -0.01 | 0.13 | 0.36 | 0.01 | -0.18 |
| Average Basic Shares Outstanding | 26.98M | 26.93M | 26.71M | 26.93M | 26.92M |
| Average Diluted Shares Outstanding | 26.98M | 26.95M | 26.71M | 26.93M | 26.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |